Drug Trial Radar · NCT03969329
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
24
Planned (sponsor's estimate)
Start
Dec 20, 2019
Primary completion
Jun 30, 2027
Study completion Jun 30, 2027
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- May 31, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Assess the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of etelcalcetide in the treatment of secondary hyperparathyroidism (SHPT) in pediatric participants between ≥ 2 to \< 18 years of age, with chronic kidney disease (CKD) on hemodialysis.
Conditions
- Secondary Hyperparathyroidism
Interventions
EtelcalcetideDrug
Etelcalcetide has been shown to be safe and efficacious in treating adult CKD patients with SHPT by simultaneously controlling iPTH, calcium (Ca), and phosphorus and has recently been approved for use in adult patients with SHPT treated with hemodialysis in both the United States and Europe.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in iPTH at Weeks 20 to 26Time frame: Baseline, Week 20 to 26
Locations
23 sites in 12 countries. Site status is shown where the registry gives one.
Universitair Ziekenhuis Gent
Ghent, Belgium · Terminated
Fakultni nemocnice v Motole
Prague, Czechia · Completed
Hospices Civils de Lyon Hopital Femme Mere Enfant
Bron, France · Terminated
Hopital Armand Trousseau
Paris, France · Completed
Kindernierenzentrum Bonn
Bonn, Germany · Completed
Universitaetsklinikum Koeln
Cologne, Germany · Recruiting
Universitaetsklinikum Hamburg Eppendorf
Hamburg, Germany · Completed
Medizinische Hochschule Hannover
Hanover, Germany · Completed
Universitaetsklinikum Heidelberg, Zentrum fuer Kinder und Jugendmedizin
Heidelberg, Germany · Recruiting
General Children Hospital Panagioti and Aglaias Kyriakou
Athens, Greece · Recruiting
Ippokrateio General Hospital of Thessaloniki
Thessaloniki, Greece · Recruiting
Semmelweis Egyetem
Budapest, Hungary · Terminated
Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar
Szeged, Hungary · Terminated
Azienda Ospedaliera Universitaria Meyer
Florence, Italy · Terminated
Childrens Hospital, Affiliate of Vilnius University Hospital Santaros Klinikos
Vilinus, Lithuania · Terminated
Uniwersytecki Szpital Dzieciecy w Krakowie
Krakow, Poland · Terminated
Unidade Local de Saude de Santo Antonio, EPE - Hospital de Santo Antonio
Porto, Portugal · Recruiting
Hospital Universitario Virgen del Rocio
Seville, Andalusia, Spain · Terminated
Hospital Universitari Vall d Hebron
Barcelona, Catalonia, Spain · Recruiting
Royal Hospital for Sick Children
Glasgow, United Kingdom · Recruiting
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom · Recruiting
Great Ormond Street Hospital for Children
London, United Kingdom · Terminated
University Hospital Southampton NHS Foundation Trust
Southampton, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.